RNAV8 BIO, INC. — Form D
RNAV8 BIO, INC. of LAGUNA NIGUEL, CA, a company, filed a Form D exempt-offering notice with the SEC on 2023-01-04. The offering totals $2.0B, of which $600K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2023-01-04
- Form: D
- Accession: 0001960745-23-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $2.0B
- Amount sold: $600K
- Remaining: $2.0B
- Investors: 11
- Date of first sale: 2022-05-09
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-469573
Issuer
- Name: RNAV8 BIO, INC.
- CIK: 0001960745
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: 29851 WEATHERWOOD, LAGUNA NIGUEL, CA, 92677
- Phone: (949) 637-2100
Officers, directors & promoters (2)
| Name | Role | Location |
|---|
| Devan Shah | Director | Laguna Niguel, CA |
| Devan Shah | Executive Officer | Laguna Niguel, CA |
Other filings by this issuer (3)
More